임상시험 연구자 지급 관리 솔루션 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 전개별, 기능성별, 최종 용도별, 결제별, 지역별 및 부문별 예측(2026-2033년)

Investigator Payment Management Solutions Market Summary

The global investigator payment management solutions market size was estimated at USD 492.02 million in 2025 and is projected to reach USD 1338.1 million by 2033, growing at a CAGR of 13.5% from 2026 to 2033. Rising investments in clinical research and biopharmaceutical R&D drive market growth.

According to the IQVIA Institute's Global Trends in R&D 2025, total R&D expenditure by large pharmaceutical companies reached about USD 190 billion in 2024, up from USD 163 billion in 2023. This increase reflects the growth in the number, scale, and geographic spread of clinical trials. The expansion creates strong demand for efficient financial management systems to handle complex investigator payments, site reimbursements, and multi-country financial operations.

Moreover, increasing investments in emerging markets such as India and other developing regions are accelerating clinical trial activity, creating a greater need for streamlined payment processes. As trials expand across multiple sites and geographies, companies face challenges with multi-currency transactions, tax compliance, and regulatory requirements. These challenges drive the adoption of automated investigator payment management solutions. In addition, strategic collaborations and large-scale investments by biopharmaceutical companies further drive clinical development activities. For instance, in January 2026, Bristol Myers Squibb entered a collaboration with Janux Therapeutics worth up to USD 850 million for cancer drug development. Such collaboration increase trial complexity, driving demand for advanced payment management solutions to ensure efficient financial workflows and compliance.

The growing adoption of integrated clinical and financial systems is significantly driving the investigator payment management solutions industry, as sponsors and CROs increasingly prefer unified platforms to streamline trial operations and financial workflows. Integrated eClinical platforms combine CTMS, EDC, ePRO, and payment functionalities, enabling seamless data flow, reducing manual intervention, and improving payment accuracy and transparency. This enhances operational efficiency and ensures faster, error-free investigator payment processing across global trials.

For instance, Mednet Solutions Inc. offers the iMednet eClinical platform, an EDC-centric solution that integrates multiple native modules such as CTMS, Payments, eConsent, RTSM, and eTMF within a single system. These integrated modules enable sponsors and CROs to manage clinical workflows and investigator payments in a unified environment, improving visibility, reducing errors, and enhancing study efficiency across all phases of clinical trials.

Global Investigator Payment Management Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global investigator payment management solutions market report based on component, deployment, functionality, end use, payment, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Software
• Services
• Deployment Outlook (Revenue, USD Million, 2021 - 2033)
• On-premise
• Cloud-based
• Functionality Outlook (Revenue, USD Million, 2021 - 2033)
• Investigator Budget Management
• Payment Calculation & Automation
• Milestone-based Payment Tracking
• Multi-Currency & Cross-Border Payment Management
• Tax & Regulatory Compliance Management
• Contract & Grant Management
• Payment Reconciliation & Audit Trail
• Financial Reporting & Analytics
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Government & Non-profit Research Organizations
• Payment Outlook (Revenue, USD Million, 2021 - 2033)
• Investigator Fees
• Site Payments
• Patient Stipend Disbursements
• Grant Payments
• Performance / Milestone-based Payments
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Component
  • 1.1.2. Deployment
  • 1.1.3. Functionality
  • 1.1.4. End Use
  • 1.1.5. Payment
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in the Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2
  • 1.9.3. Objective 3

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component
  • 2.2.2. Deployment outlook
  • 2.2.3. Functionality outlook
  • 2.2.4. End use outlook
  • 2.2.5. Payment outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Investigator Payment Management Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Reimbursement framework
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising Investments in Clinical Research and Biopharmaceutical R&D
    • 3.3.1.2. Rising Outsourcing to CROs and Technology Vendors
    • 3.3.1.3. Growing need for transparency and regulatory compliance
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High implementation costs and slow adoption among small organizations
    • 3.3.2.2. Data privacy and security concerns
  • 3.3.3. Industry Challenge
• 3.4. Investigator Payment Management Solutions Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Economic landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Investigator Payment Management Solutions Market: Component Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Segment Dashboard
• 4.3. Global Investigator Payment Management Solutions Market by Deployment Outlook
  • 4.3.1. Software
    • 4.3.1.1. Software market estimates and forecast 2021 to 2033 (USD Million)
  • 4.3.2. Services
    • 4.3.2.1. Services market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Investigator Payment Management Solutions Market: Deployment Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Segment Dashboard
• 5.3. Global Investigator Payment Management Solutions Market by Deployment Outlook
  • 5.3.1. Cloud-based
    • 5.3.1.1. Cloud-based market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.2. On-premise
    • 5.3.2.1. On-premise market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Investigator Payment Management Solutions Market: Functionality Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Segment Dashboard
• 6.3. Global Investigator Payment Management Solutions Market by Functionality Outlook
  • 6.3.1. Investigator Budget Management
    • 6.3.1.1. Investigator Budget Management market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.2. Payment Calculation & Automation
    • 6.3.2.1. Payment Calculation & Automation market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.3. Milestone-based Payment Tracking
    • 6.3.3.1. Milestone-based Payment Tracking estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.4. Multi-Currency & Cross-Border Payment Management
    • 6.3.4.1. Multi-Currency & Cross-Border Payment Management estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.5. Tax & Regulatory Compliance Management
    • 6.3.5.1. Tax & Regulatory Compliance Management market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.6. Contract & Grant Management
    • 6.3.6.1. Contract & Grant Management market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.7. Payment Reconciliation & Audit Trail
    • 6.3.7.1. Payment Reconciliation & Audit Trail market estimates and forecast 2021 to 2033 (USD Million)
  • 6.3.8. Financial Reporting & Analytics
    • 6.3.8.1. Financial Reporting & Analytics market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Investigator Payment Management Solutions Market: End Use Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. Segment Dashboard
• 7.3. Global Investigator Payment Management Solutions Market by Application Outlook
  • 7.3.1. Pharmaceutical Companies
    • 7.3.1.1. Pharmaceutical Companies market estimates and forecast 2021 to 2033 (USD Million)
  • 7.3.2. Biotechnology Companies
    • 7.3.2.1. Biotechnology Companies market estimates and forecast 2021 to 2033 (USD Million)
  • 7.3.3. Contract Research Organizations (CROs)
    • 7.3.3.1. Contract Research Organizations market estimates and forecast 2021 to 2033 (USD Million)
  • 7.3.4. Academic & Research Institutes
    • 7.3.4.1. Academic & Research Institutes market estimates and forecast 2021 to 2033 (USD Million)
  • 7.3.5. Government & Non-profit Research Organizations
    • 7.3.5.1. Government & Non-profit Research Organizations market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Investigator Payment Management Solutions Market: Payment Estimates & Trend Analysis

• 8.1. Definitions and Scope
• 8.2. Segment Dashboard
• 8.3. Global Investigator Payment Management Solutions Market by Payment Outlook
  • 8.3.1. Investigator Fees
    • 8.3.1.1. Investigator Fees market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.2. Site Payments
    • 8.3.2.1. Site Payments market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.3. Patient Stipend Disbursements
    • 8.3.3.1. Patient Stipend Disbursements market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.4. Grant Payments
    • 8.3.4.1. Grant Payments market estimates and forecast 2021 to 2033 (USD Million)
  • 8.3.5. Performance / Milestone-based Payments
    • 8.3.5.1. Performance / Milestone-based Payment's market estimates and forecast 2021 to 2033 (USD Million)

Chapter 9. Investigator Payment Management Solutions Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2025 & 2033
• 9.2. Regional Market Dashboard
• 9.3. Regional Market Snapshot
• 9.4. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2033
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.6. Sweden
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.7. Denmark
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.6.8. Norway
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.4. South Korea
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.5. Thailand
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.7.6. Australia
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Key Company Market Share Analysis, 2025 (%)
• 10.4. Key Company Market Position Analysis, 2025
• 10.5. Company Profiles
  • 10.5.1. Suvoda LLC (in April 2025 merged with Greenphire)
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. IQVIA
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. Oracle
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. Medidata
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. Veeva Systems Inc.
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. Advarra (Forte Research Systems)
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. ICON plc
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. SiteDocs
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. LedgerRun
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Simplified Clinical Data Systems
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. IF-RS
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Prevail InfoWorks
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. Sitero
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. WCG Clinical
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product benchmarking
    • 10.5.14.4. Strategic initiatives